Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT03904693 · COMPLETED
Trial details
- NCT number
- NCT03904693
- Sponsor
- Actelion
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-29
- Primary completion
- 2022-08-23
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.